Our current study revealed that aberrant miR-34c-5p/KLF4/β-catenin signaling is the crucial mechanism of GDD occurrence and further provides new insights into the clinical treatment of GDD by targeting miR-34c-5p. Here, KLF4 is linked to gnathodiaphyseal dysplasia.